Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19
Description
CONCLUSION: At-home, antiviral treatment with RD-X19 or other interventions with similar efficacy that decrease both symptomatic days and transmission probabilities can be used in concert with vaccines to reduce COVID-19 cases, deaths, and direct
